{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:54:36Z","timestamp":1720677276177},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T00:00:00Z","timestamp":1164067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,6,27]]},"DOI":"10.1007\/s10067-006-0473-1","type":"journal-article","created":{"date-parts":[[2006,11,20]],"date-time":"2006-11-20T07:31:40Z","timestamp":1164007900000},"page":"1328-1331","source":"Crossref","is-referenced-by-count":9,"title":["Anti-p53 antibodies in patients with dermatomyositis\/polymyositis"],"prefix":"10.1007","volume":"26","author":[{"given":"Yoshihiro","family":"Mimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenshirou","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,21]]},"reference":[{"key":"473_CR1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1001\/archinte.1985.00360100097016","volume":"145","author":"LE Manchul","year":"1985","unstructured":"Manchul LE, Pritchard KJ, Tenenbaum J et al (1985) The frequency of malignant neoplasms in patients with polymyositis\u2013dermatomyositis. Arch Intern Med 145:1835\u20131839","journal-title":"Arch Intern Med"},{"key":"473_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindel\u00f6f B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 326:363\u2013367","journal-title":"N Engl J Med"},{"key":"473_CR3","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1038\/jid.1993.36","volume":"100","author":"P Bernard","year":"1993","unstructured":"Bernard P, Bonnetblanc JM (1993) Dermatomyositis and malignancy. J Invest Dermatol 100:128S\u2013132S","journal-title":"J Invest Dermatol"},{"key":"473_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910300404","volume":"30","author":"LV Crawford","year":"1982","unstructured":"Crawford LV, Pim DC, Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30:403\u2013408","journal-title":"Int J Cancer"},{"key":"473_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP (1992) p53, guardian of the genome. Nature 358:15\u201316","journal-title":"Nature"},{"key":"473_CR6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM199403243301215","volume":"330","author":"M M\u00fcller","year":"1994","unstructured":"M\u00fcller M, Volkmann M, Zentgraf H, Galle PR (1994) Clinical implications of the p53 tumor suppressor gene (letter). N Engl J Med 330:864\u2013865","journal-title":"N Engl J Med"},{"key":"473_CR7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ijc.2910580404","volume":"58","author":"K Angelopoulou","year":"1994","unstructured":"Angelopoulou K, Diamandis EP, Sutherland DJ, Kellen JA, Bunting PS (1994) Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int J Cancer 58:480\u2013487","journal-title":"Int J Cancer"},{"key":"473_CR8","first-page":"3468","volume":"53","author":"S Labrecque","year":"1993","unstructured":"Labrecque S, Naor N, Thomson D, Matlashewski G (1993) Analysis of the anti-p53 antibody response in cancer patients. Cancer Res 53:3468\u20133471","journal-title":"Cancer Res"},{"key":"473_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"473_CR10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","volume":"44","author":"Y Asano","year":"2001","unstructured":"Asano Y, Ihn H, Yamane K et al (2001) Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum 44:1363\u20131369","journal-title":"Arthritis Rheum"},{"key":"473_CR11","doi-asserted-by":"crossref","unstructured":"Soussi T (1996) The p53 tumor suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 32\u201337","DOI":"10.1016\/1357-4310(96)88756-9"},{"key":"473_CR12","first-page":"1777","volume":"60","author":"T Soussi","year":"2000","unstructured":"Soussi T (2000) p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60:1777\u20131788","journal-title":"Cancer Res"},{"key":"473_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF01209124","volume":"122","author":"D Coomber","year":"1996","unstructured":"Coomber D, Hawkins NJ, Clark M et al (1996) Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer. J Cancer Res Clin Oncol 122:757\u2013762","journal-title":"J Cancer Res Clin Oncol"},{"key":"473_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/IJGC:31:1-3:129","volume":"31","author":"G Ohshio","year":"2002","unstructured":"Ohshio G, Suwa H, Imamura M (2002) Clinical implication of anti-p53 antibodies and p53-protein in pancreatic disease. Int J Gastrointest Cancer 31:129\u2013135","journal-title":"Int J Gastrointest Cancer"},{"key":"473_CR15","first-page":"643","volume":"18","author":"F Falcini","year":"2000","unstructured":"Falcini F, Calzolari A, Generini S et al (2000) Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. Clin Exp Rheumatol 18:643\u2013646","journal-title":"Clin Exp Rheumatol"},{"key":"473_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<63::AID-PATH303>3.0.CO;2-E","volume":"188","author":"JL Pablos","year":"1999","unstructured":"Pablos JL, Santiago B, Galindo M et al (1999) Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 188:63\u201368","journal-title":"J Pathol"},{"key":"473_CR17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gut.42.6.899","volume":"42","author":"H Fricke","year":"1998","unstructured":"Fricke H, Urban S, Noehl N et al (1998) Serum p53 antibodies in patients with chronic inflammatory bowel disease. Gut 42:899","journal-title":"Gut"},{"key":"473_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00054725-200409000-00016","volume":"10","author":"M Cioffi","year":"2004","unstructured":"Cioffi M, Riegler G, Vietri MT et al (2004) Serum p53 antibodies in patients affected with ulcerative colitis. Inflamm Bowel Dis 10:606\u2013611","journal-title":"Inflamm Bowel Dis"},{"key":"473_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1399-3038.2003.00033.x","volume":"14","author":"ZA El-Sayed","year":"2003","unstructured":"El-Sayed ZA, Farag DH, Eissa S (2003) Tumor suppressor protein p53 and anti-p53 autoantibodies in pediatric rheumatological diseases. Pediatr Allergy Immunol 14:229\u2013233","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0473-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0473-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:03Z","timestamp":1559105463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0473-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,21]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,6,27]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0473-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,21]]}}}